In vitro activity of ceftobiprole and seven other antimicrobial agents against invasive Streptococcus pneumoniae isolates in Spain

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 12, 2011, Pages 1621-1625

  Rios Duenas E ^a   Rodriguez Avial I ^a   Picazo, J J ^a  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTOBIPROLE; CLINDAMYCIN; ERYTHROMYCIN; MOXIFLOXACIN; PENICILLIN G; TELITHROMYCIN; TETRACYCLINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BROTH DILUTION; CONTROLLED STUDY; ERM(B) GENE; IN VITRO STUDY; MEF(A/E) GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SEROTYPE; SPAIN; SPECIES DISTRIBUTION; STREPTOCOCCUS PNEUMONIAE;

ADULT; ANTI-INFECTIVE AGENTS; CEPHALOSPORINS; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; SEROTYPING; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 83655201446     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1340-9     Document Type: Article

References (26)

1. C Ardanuy F Tubau R Pallares L Calatayud A Dominguez Maria D Rolo I Grau R Martin J Liñares 2009 Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007 Clin Microbiol Infect 48 1 57 64
2. A Fenoll JJ Granizo L Aguilar MJ Gimenez L Aragoneses-Fenoll G Hanquet J Casal D Tarrago 2009 Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007 J Clin Microbiol 47 4 1012 1020 19225097 10.1128/JCM.01454-08 1:CAS:528: DC%2BD1MXlvVamsbc%3D
3. CA Lexau R Lynfield R Danila T Pilishvili R Facklam MM Farley LH Harrison W Schaffner A Reingold NM Bennett J Hadler PR Cieslak CG Whitney for the Active Bacterial Core Surveillance T 2005 Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine JAMA 294 16 2043 2051 16249418 10.1001/jama.294.16.2043 1:CAS:528:DC%2BD2MXhtFKhu7fL (Pubitemid 41539937)
4. C Muñoz-Almagro I Jordan A Gene C Latorre J Garcia-Garcia Juan R Pallares 2008 Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine Clin Infect Dis 46 2 174 182 18171247 10.1086/524660 (Pubitemid 351269154)
5. CG Whitney MM Farley J Hadler LH Harrison NM Bennett R Lynfield A Reingold PR Cieslak T Pilishvili D Jackson RR Facklam JH Jorgensen A Schuchat the Active Bacterial Core Surveillance of the Emerging Infections Program N 2003 Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine N Engl J Med 348 18 1737 1746 12724479 10.1056/NEJMoa022823 (Pubitemid 36514704)
6. J Picazo J Ruiz-Contreras J Casado-Flores E Giangaspro F Del Castillo T Hernandez-Sampelayo E Otheo F Balboa E Rios C Mendez 2011 Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar Clin Vaccine Immunol 18 1 89 94 21047996 10.1128/CVI.00317-10 1:CAS:528:DC%2BC3MXpslWmsQ%3D%3D
7. R Dagan 2009 Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae Clin Microbiol Infect 15 16 20 19366365 10.1111/j.1469-0691.2009.02726.x 1:CAS:528:DC%2BD1MXmt1Shsro%3D
8. MH Kyaw R Lynfield W Schaffner AS Craig J Hadler A Reingold AR Thomas LH Harrison NM Bennett MM Farley RR Facklam JH Jorgensen J Besser ER Zell A Schuchat CG Whitney Active Bacterial Core Surveillance of the Emerging Infections Program N 2006 Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 354 14 1455 1463 16598044 10.1056/NEJMoa051642 1:CAS:528:DC%2BD28XjtFWhtrs%3D
9. P Hebeisen I Heinze-Krauss P Angehrn P Hohl MGP Page RL Then 2001 In vitro and In vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococci Antimicrob Agents Chemother 45 3 825 836 11181368 10.1128/AAC.45.3.825-836.2001 1:CAS:528:DC%2BD3MXhsFWgur8%3D (Pubitemid 32182033)
10. K Kosowska DB Hoellman G Lin C Clark K Credito P McGhee B Dewasse B Bozdogan S Shapiro PC Appelbaum 2005 Antipneumococcal activity of ceftobiprole, a novel broad-spectrum cephalosporin Antimicrob Agents Chemother 49 5 1932 1942 15855516 10.1128/AAC.49.5.1932-1942.2005 1:CAS:528:DC%2BD2MXktFSntLk%3D (Pubitemid 40631609)
11. TA Davies W Shang K Bush 2006 Activities of ceftobiprole and other {beta}-lactams against Streptococcus pneumoniae clinical isolates from the United States with defined substitutions in penicillin-binding proteins PBP 1a, PBP 2b, and PBP 2x Antimicrob Agents Chemother 50 7 2530 2532 16801437 10.1128/AAC.00238-06 1:CAS:528:DC%2BD28XmvVWrt74%3D (Pubitemid 43993197)
12. LM Deshpande RN Jones 2003 Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3-ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococci Clin Microbiol Infect 9 11 1120 1124 14616730 10.1046/j.1469-0691.2003.00765.x 1:CAS:528:DC%2BD3sXpvFChsbk%3D (Pubitemid 37428051)
13. Clinical Laboratory Standards Institute C (2008) Performance standards for antimicrobial susceptibility testing; 18th informational supplement M100-S18. Wayne, PA, USA
14. J Sutcliffe T Grebe A Tait-Kamradt L Wondrack 1996 Detection of erythromycin-resistant determinants by PCR Antimicrob Agents Chemother 40 11 2562 2566 8913465 1:CAS:528:DyaK28Xms1Smsb8%3D (Pubitemid 26367644)
15. A Rosato H Vicarini R Leclercq 1999 Inducible or constitutive expression of resistance in clinical isolates of streptococci and enterococci cross-resistant to erythromycin and lincomycin J Antimicrob Chemother 43 4 559 562 10350387 10.1093/jac/43.4.559 1:CAS:528:DyaK1MXivVynsbc%3D (Pubitemid 29182307)
16. MM Daly S Doktor R Flamm D Shortridge 2004 Characterization and Prevalence of mefA, mefE, and the Associated msr(D) Gene in Streptococcus pneumoniae Clinical Isolates J Antimicrob Chemother 42 3570 3574 1:CAS:528:DC%2BD2cXnt1Ogt7s%3D (Pubitemid 39045682)
17. LA Hicks LH Harrison B Flannery J Hadler W Schaffner A Craig D Jackson A Thomas B Beall R Lynfield A Reingold M Farley C Whitney 2007 Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004 J Infect Dis 196 9 1346 1354 17922399 10.1086/521626 (Pubitemid 351412007)
18. E Pérez-Trallero JM Marimon M Ercibengoa D Vicente EG P-Y 2009 Invasive Streptococcus pneumoniae infections in children and older adults in the north of Spain before and after the introduction of the heptavalent pneumococcal conjugate vaccine Eur J Clin Microbiol Infect Dis 28 731 738 19153783 10.1007/s10096-008-0693-1
19. C Ardanuy D Rolo A Fenoll D Tarrago L Calatayud J Linares 2009 Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain J Antimicrob Chemother 64 507 510 19535383 10.1093/jac/dkp210 1:CAS:528:DC%2BD1MXhtVWju7vF
20. MR Moore RE Gertz RL Woodbury GA Barkocy-Gallagher W Schaffner C Lexau K Gershman A Reingold M Farley L Harrison JL Hadler NM Bennett AR Thomas L McGee T Pilishvili AB Brueggemann CG Whitney JH Jorgensen B Beall 2008 Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005 J Infect Dis 197 7 1016 1027 18419539 10.1086/528996 (Pubitemid 351590031)
21. L Calatayud C Ardanuy F Tubau D Rolo I Grau R Pallares R Martin J Linares 2010 Serotype and genotype replacement among macrolide-resistant invasive pneumococci in adults: mechanisms of resistance and association with different transposons J Clin Microbiol 48 4 1310 1316 20147647 10.1128/JCM.01868-09
22. J-H Song 2008 What's new on the antimicrobial horizon? Int J Antimicrob Agents 32 Suppl 4 S207 S213 19134521 10.1016/S0924-8579(09)70004-4 1:CAS:528:DC%2BD1MXmtV2qsw%3D%3D
23. CM Pillar MK Aranza D Shah DF Sahm 2008 In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent Gram-positive and Gram-negative isolates of European origin J Antimicrob Chemother 61 3 595 602 18218646 10.1093/jac/dkm492 1:CAS:528:DC%2BD1cXisVKntbs%3D (Pubitemid 351321133)
24. C Betriu E Culebras M Gómez F López-Fabal I Rodríguez-Avial JJ Picazo 2010 Comparative in vitro activity of ceftobiprole against Gram-positive cocci Int J Antimicrob Agents 36 2 111 113 20554163 10.1016/j.ijantimicag.2010.04.003 1:CAS:528:DC%2BC3cXnvVOrt7g%3D
25. RN Jones LM Deshpande AH Mutnick DJ Biedenbach 2002 In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci J Antimicrob Chemother 50 6 915 932 12461013 10.1093/jac/dkf249 1:CAS:528:DC%2BD38XptlOitrc%3D (Pubitemid 36032813)
26. A Barbour S Schmidt KH Rand H Derendorf 2009 Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) Int J Antimicrob Agents 34 1 1 7 19261449 10.1016/j.ijantimicag.2008.12.012 1:CAS:528: DC%2BD1MXmsVSiurk%3D